Rodin Therapeutics, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Rodin Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $217,210 in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2017.
Rodin Therapeutics at a glance
What does Rodin Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $217,210 in total (2015).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10.8 million sold (2017).
Frequently asked questions about Rodin Therapeutics
Where is Rodin Therapeutics headquartered?
Rodin Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Rodin Therapeutics do?
Rodin Therapeutics, Inc. is a biotechnology company.
When was Rodin Therapeutics founded?
The earliest incorporation on record for Rodin Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences